Histopathology of Barrett esophagus

Lysandra Voltaggio, Elizabeth A. Montgomery

Research output: Contribution to journalArticlepeer-review


Barrett esophagus (BE) is a metaplastic, premalignant lesion of the tubular esophagus that carries significant implications and is associated with approximately 0.5% annual cancer incidence. Although gastroesophageal reflux disease is a recognized risk factor, no clear guidelines exist as to who should undergo endoscopic screening for the condition. Histologic requirements for the diagnosis vary by geographic region with some but not all countries requiring the presence of goblet cells. In spite of interobserver variability, histologic assessment of dysplasia is currently the accepted method of surveillance and subsequent patient management is dictated by this evaluation. Though not universal, endoscopic therapy is rapidly replacing esophagectomy in patients with high-grade dysplasia/early carcinoma. This review aims to provide the reader with an overview on this subject with special emphases on the histopathologic features of BE and BE-associated dysplasia as well as evolution and new developments related to therapeutic modalities in patients diagnosed with dysplasia.

Original languageEnglish (US)
Pages (from-to)41-49
Number of pages9
JournalDiagnostic Histopathology
Issue number2
StatePublished - Feb 2011
Externally publishedYes


  • Adenocarcinoma
  • Barrett
  • Dysplasia
  • Review

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology


Dive into the research topics of 'Histopathology of Barrett esophagus'. Together they form a unique fingerprint.

Cite this